Akorn - 17 Year Stock Split History | AKRX

Stock split history for Akorn since 2002. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Akorn Annual Stock Splits
Akorn Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.322B $0.694B
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.285B 9.36
Mylan (MYL) United Kingdom $9.084B 4.00
Bausch Health Cos (BHC) Canada $7.347B 4.90
Teva Pharmaceutical Industries (TEVA) Israel $6.726B 2.64
Dr Reddy's Laboratories (RDY) India $5.793B 19.49
ASPEN PHARMACR (APNHY) South Africa $2.008B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.417B 13.85
Amphastar Pharmaceuticals (AMPH) United States $0.987B 48.60
Voyager Therapeutics (VYGR) United States $0.762B 0.00
Homology Medicines (FIXX) United States $0.692B 0.00
CymaBay Therapeutics (CBAY) United States $0.403B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.344B 0.47
Assembly Biosciences (ASMB) United States $0.316B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.311B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.246B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.174B 0.00
Sol-Gel Technologies (SLGL) Israel $0.156B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.093B 0.00
Teligent (TLGT) United States $0.037B 0.00